Deborah Wong

9PUBLICATIONS

97CO-AUTHORS

Predictive and prognostic markersCancer diagnosisAllergyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 08, 2026

Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.

|Dec 04, 2025

Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck Consortium.

Allen S Ho, Justin T Moyers, Shirin Attarian

|Jun 11, 2025

Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or Lymphomas.

Kevin J Harrington, Stephane Champiat, Joshua D Brody

|Sep 14, 2024

Therapeutic Advances in Advanced Basal Cell Carcinoma.

Samer Alkassis, Maya Shatta, Deborah J Wong

|Aug 29, 2023

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.

Glenn J Hanna, Myung-Ju Ahn, Jameel Muzaffar

|Dec 15, 2022

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.

Emrullah Yilmaz, Nofisat Ismaila, Julie E Bauman

Pageof 2

Frequent Collaborators

Emrullah Yilmaz

Sung-Bae Kim

Glenn J Hanna

Loren K Mell

Michael Jameson

Orlando Guntinas-Lichius

Eric Whitman

Robert Janssen

Alain P Algazi

Patricia M LoRusso

Frequent Collaborators

Emrullah Yilmaz

Sung-Bae Kim

Glenn J Hanna

Loren K Mell